Does ALPELISIB Cause Decreased appetite? 546 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 546 reports of Decreased appetite have been filed in association with ALPELISIB (PIQRAY). This represents 6.5% of all adverse event reports for ALPELISIB.
546
Reports of Decreased appetite with ALPELISIB
6.5%
of all ALPELISIB reports
28
Deaths
102
Hospitalizations
How Dangerous Is Decreased appetite From ALPELISIB?
Of the 546 reports, 28 (5.1%) resulted in death, 102 (18.7%) required hospitalization, and 9 (1.6%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ALPELISIB.
What Other Side Effects Does ALPELISIB Cause?
Hyperglycaemia (1,575)
Rash (1,393)
Diarrhoea (1,336)
Blood glucose increased (1,105)
Death (921)
Nausea (860)
Fatigue (817)
Weight decreased (508)
Malignant neoplasm progression (497)
Vomiting (479)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ALPELISIB Alternatives Have Lower Decreased appetite Risk?
ALPELISIB vs ALPHA.-LIPOIC ACID
ALPELISIB vs ALPHA.-TOCOPHEROL
ALPELISIB vs ALPHA.-TOCOPHEROL, D-
ALPELISIB vs ALPHA.-TOCOPHEROL, DL-
ALPELISIB vs ALPHA.1-PROTEINASE INHIBITOR HUMAN